The new study reverses some of the conclusions of the Women's Health Initiative, a study that made doctors and the general ...
More than two decades ago, the shocking results of a major women’s health study challenged the safety of menopause hormones, and overnight, millions of women and their doctors abandoned the ...
An older form of hormone therapy taken to ease the symptoms of menopause could increase the risk of ovarian cancer, according to results released Thursday from two studies involving tens of ...
Researchers examined 453 menopausal women aged 40–65 with moderate or severe hot flushes who were unsuitable for hormone replacement therapy, after giving them 45mg of fezolinetant or placebo ...
Moderate to severe hot flashes may triple the risk of metabolic dysfunction steatotic liver disease, a study suggests.
Researchers found un-immediate relatives – ie grandparents, aunts, uncles, nieces and nephews – were 1.5 times more likely to get colon cancer if their relative had started the menopause early ...
If exercise seems to trigger hot flashes, switching to lower-intensity activities could help reduce hot flash frequency.
Opinions expressed by Forbes Contributors are their own. I am a law professor covering the future of work. With women ages 45 ...
Research, by her menopause clinic Newson Health, found almost a third of women had between two and five medical appointments before their symptoms were diagnosed as linked to the perimenopause and ...
The findings, from two trials involving tens of thousands of women, could influence guidelines around the use of hormonal treatment for menopausal symptoms.
Fezolinetant reduces the frequency and severity of hot flushes during menopause for 24 weeks, without serious side effects, according to research presented at the 26th European Congress of ...
Women are being forced to attend up to 10 GP appointments to get a menopause diagnosis, first-of-its-kind research has found. The UK’s largest ever polling of perimenopausal and menopausal women, ...